Butonitazene
| Butonitazene | |
|---|---|
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 424.5 g/mol [1] |
| Predicted LogP | 5.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C24H32N4O3 [1] |
| IUPAC name | 2-[2-[(4-butoxyphenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-diethylethanamine [1] |
| SMILES | CCCCOC1=CC=C(C=C1)CC2=NC3=C(N2CCN(CC)CC)C=CC(=C3)[N+](=O)[O-] [1] |
| InChI | InChI=1S/C24H32N4O3/c1-4-7-16-31-21-11-8-19(9-12-21)17-24-25-22-18-20(28(29)30)10-13-23(22)27(24)15-14-26(5-2)6-3/h8-13,18H,4-7,14-17H2,1-3H3 [1] |
| InChIKey | UZZPOLCDCVWLAZ-UHFFFAOYSA-N [1] |
Butonitazene (also known as 1H-Benzimidazole-1-ethanamine, 2-((4-butoxyphenyl)methyl)-N,N-diethyl-5-nitro-, 2-[(4-butoxyphenyl)methyl]-N,N-diethyl-5-nitro-1H-benzimidazole-1-ethanamine, Chebi:234364, 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, butoxynitazene, Epitope ID:2278941, Dea no. 9751, EX-A6016, 2-(p-butoxybenzyl)-1-[2-(diethylamino)ethyl]-5-nitrobenzimidazole or 2-[2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl]-N,N-diethylethanamine) is a opioid substance of the nitazene class.
Chemistry
Stereochemistry []
Butonitazene is a achiral mixture.
Subjective effects []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 156588955, Butonitazene. Accessed June 7, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/156588955
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Butonitazene. UNII: C4CE9FVR7N. Global Substance Registration System. Accessed June 7, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/C4CE9FVR7N